RE: Getting worried8 Jan 2021 14:42
@zum - Frustrating times indeed! The fact the Phase 2 INTREST Trial showed such promising results with Traumakine the SP went upto £8. Ok granted, there was only 29m shares in circulation at the time giving us a mcap of 230m. At the time Clevegen wasn't even in the headlines back then.
Hindsight is a wonderful thing and maybe Marku regrets putting his eggs in the hands of REMAP & Solidarity as they've been dropped big time! Maybe, just maybe, HIBISCUS will give us that double yolker that we're all craving.
Traumakine hasn't been wrote off in any trials its just sounds like its been barely used!!
Last update on C wasn't anything we didn't already know really. News normally released every 3 month so id envisage next update mid February.
MCAP in my opinion is ridiculously low considering we're still fighting on both fronts!